| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.STR.29.3.577 |
| P698 | PubMed publication ID | 9506595 |
| P50 | author | Bruce M. Psaty | Q30429993 |
| William T. Longstreth | Q123220049 | ||
| P2093 | author name string | T D Koepsell | |
| S M Schwartz | |||
| D S Siscovick | |||
| P H Reitsma | |||
| F R Rosendaal | |||
| T E Raghunathan | |||
| H L Vos | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Factor V Leiden | Q185986 |
| P304 | page(s) | 577-580 | |
| P577 | publication date | 1998-03-01 | |
| P1433 | published in | Stroke Journal | Q7624282 |
| P1476 | title | Risk of stroke in young women and two prothrombotic mutations: factor V Leiden and prothrombin gene variant (G20210A) | |
| P478 | volume | 29 |
| Q36100026 | Activated Protein C Resistance Does Not Increase Risk for Recurrent Stroke or Death in Stroke Patients |
| Q43626449 | Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. |
| Q28195140 | Antithrombotic drug treatment of pediatric patients with ischemic stroke |
| Q36277248 | Antithrombotic therapy for stroke in young adults |
| Q35134524 | Arterial thromboembolism in pregnancy |
| Q63368005 | Arterial wall thickness and the risk of recurrent ischemic events in carriers of the prothrombin G20210A mutation with clinical manifestations of atherosclerosis |
| Q35602154 | Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies |
| Q43726112 | Cerebral vein thrombosis and prothrombin gene (G20210A) mutation |
| Q35291832 | Clinical significance of gene-diagnosis for defects in coagulation factors and inhibitors |
| Q73275029 | Coexistence of two prothrombotic mutations, factor V 1691 G-A and prothrombin gene 20210 G-A, and the risk of cerebral infarct in pediatric patients |
| Q43633269 | Correlation of polymorphisms to coagulation and biochemical risk factors for cardiovascular diseases |
| Q48533506 | Elevated prothrombin is a risk factor for cerebral arterial ischemia in young adults |
| Q35560338 | Evaluation of the modifying effects of unfavourable genotypes on classical clinical risk factors for ischaemic stroke |
| Q73406800 | Evaluation of the poly(ADP-ribose) polymerase gene in human stroke |
| Q37705853 | Factor V Leiden does not have a role in cryptogenic ischemic stroke among Iranian young adults |
| Q35784160 | Factor V leiden and ischemic stroke risk: the Genetics of Early Onset Stroke (GEOS) study |
| Q48309458 | Factor V leiden and prothrombin gene G20210A mutation in children with cerebral thromboembolism |
| Q37041027 | Factor VLeiden and prothrombin G20210A gene polymorphisms in patients with coronary artery disease |
| Q73647308 | Familial thrombophilia and retinal vein occlusion |
| Q35008517 | Genetics of ischemic stroke. |
| Q90250080 | Inherited Thrombophilia and the Risk of Arterial Ischemic Stroke: A Systematic Review and Meta-Analysis |
| Q33348319 | Inherited thrombophilias and anticoagulation in pregnancy |
| Q44426328 | Large volume donor plasmapheresis in inherited thrombophilia implicated in arterial thrombosis. |
| Q35234137 | Meta-analysis of factor V Leiden and ischemic stroke in young adults: the importance of case ascertainment |
| Q46715240 | Prothrombin G20210A and factor V Leiden polymorphisms in stroke |
| Q33724615 | Prothrombin G20210A mutation is associated with young-onset stroke: the genetics of early-onset stroke study and meta-analysis |
| Q34472618 | Risk factors for ischemic stroke and transient ischemic attack in patients under age 50 |
| Q35148395 | Screening for hypercoagulable syndromes following stroke |
| Q24794936 | The Ischemic Stroke Genetics Study (ISGS) Protocol |
| Q24803218 | The Siblings With Ischemic Stroke Study (SWISS) protocol |
| Q33384443 | The genetics of primary haemorrhagic stroke, subarachnoid haemorrhage and ruptured intracranial aneurysms in adults |
| Q31899830 | The plasminogen activator inhibitor (PAI)-1 promoter 4G/4G genotype is not associated with ischemic stroke in a population of German children. Childhood Stroke Study Group |
| Q33918597 | Thrombophilia, polymorphisms, and vascular disease |
| Q81153272 | [Cerebral infarction of arterial origin and haematological causation: the Lausanne experience and a review of the literature] |
Search more.